The Clinical Validity of Prior Catheter Ablation for Prevention of Recurrent Atrial Fibrillation after Transcatheter Closure of Atrial Septal Defect
| Project/Area Number |
26860562
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Cardiovascular medicine
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2014-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 心房中隔欠損症 / 心房細動 / カテーテルアブレーション |
|---|
| Outline of Final Research Achievements |
In this study, the efficacy of prior Catheter ablation (CA) for prevent of recurrent AF after transcatheter ASD closure were assessed. We evaluated consecutive 52 patients (age, 67 ± 12 years) who complicated with paroxysmal or persistent AF before transcatheter ASD closure. Among them, 35 patients had been undergone CA for AF prior to ASD closure. During the follow-up period after ASD closure, recurrence of AF was observed in 3 of 35 (9%) with CA, contrary in 10 of 17 (59%) without CA (P< 0.001). Prior CA was an independent favorable parameter for AF free survival (p<0.01). Prior CA for AF is a valid therapeutic strategy for reducing the recurrence of AF after transcatheter ASD closure.
|
Report
(3 results)
Research Products
(2 results)
